Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
64.90
+0.39 (0.60%)
May 30, 2025, 11:30 AM CST
Hangzhou Alltest Biotech Market Cap
Hangzhou Alltest Biotech has a market cap or net worth of 5.02 billion as of May 29, 2025. Its market cap has decreased by -4.60% in one year.
Market Cap
5.02B
Enterprise Value
2.48B
Revenue
875.14M
Ranking
n/a
PE Ratio
15.99
Stock Price
64.90
Market Cap Chart
Since March 25, 2021, Hangzhou Alltest Biotech's market cap has decreased from 9.38B to 5.02B, a decrease of -46.42%. That is a compound annual growth rate of -13.87%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 29, 2025 | 5.02B | 2.32% |
Dec 31, 2024 | 4.91B | -8.43% |
Dec 29, 2023 | 5.36B | -2.86% |
Dec 30, 2022 | 5.52B | -16.76% |
Dec 31, 2021 | 6.63B | -29.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 353.56B |
Shenzhen Mindray Bio-Medical Electronics | 274.87B |
WuXi AppTec | 177.61B |
Zhangzhou Pientzehuang Pharmaceutical., | 123.12B |
Aier Eye Hospital Group | 115.99B |
Shanghai United Imaging Healthcare | 112.88B |
Sichuan Biokin Pharmaceutical | 108.31B |
Yunnan Baiyao Group Co.,Ltd | 100.20B |